niryuu/sni-each-converted huggingface dataset:
After intravitreal injection of triamcinolone acetonide, cataract may rapidly develop in eyes that have been intensively treated, topically and systemically, by corticosteroids for several years.
Output: triamcinolone acetonide
Our literature review revealed an additional six cases of onset of inflammatory arthritis in MS patients receiving IFN-beta.
Output: IFN-beta
The first patient developed a monoarthritis 2 weeks after initiation of IFN-beta, which persisted during the 14 months of therapy and resolved with discontinuation of the medication.
Output: IFN-beta
Therapy with IFN-beta has rarely been associated with the development of autoimmune disorders.
Output: IFN-beta
We present the cases of two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS) who developed inflammatory musculoskeletal manifestations, following IFN-beta therapy.
Output: IFN-beta
Trimethoprim-sulfamethoxazole-induced aseptic meningitis.
Output: Trimethoprim-sulfamethoxazole
In this paper, we report a patient with primary anti-phospholipid syndrome treated by corticosteroid, who developed disseminated nocardiosis.
Output: corticosteroid
Chloroquine-induced bilateral ptosis.
Output: Chloroquine
This report describes a case of bilateral ptosis induced by chloroquine.
Output: chloroquine
DESIGN: We reviewed the medical records of four patients, who were seen by us between July 2000 and February 2004 for sudden onset of a central neurological syndrome within days of intrathecal MTX.
Output: MTX
Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.
Output: methotrexate
Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered subacute neurotoxicity after intrathecal MTX.
Output: MTX
This is a rare case of ARDS associated with lithium intoxication.
Output: lithium
CONCLUSION: The present findings suggest that: (i) amantadine probably exerts its anti-dyskinetic effect by acting on the "indirect" pathway; (ii) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in L-dopa induced dyskinesias; (iii) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
Output: L-dopa
Prior to surgery, levodopa induced dyskinesia had improved (< or = 50%) under treatment with amantadine (400 mg/day, po) in all three patients.
Output: levodopa
A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent triazolam-induced eating disorder.
Output: triazolam
Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of sarcoidosis associated with interferon alpha therapy have been reported.
Output: interferon alpha
In this paper, we report a case of severe hypercalcemia of immobilization in a 40-year-old hemodialyzed woman treated by cinacalcet HCl for a severe HPTH-II (PTH>1,000 pg/mL).
Output: cinacalcet HCl
Here, we present a case of sirolimus-associated interstitial pneumonitis in a cardiac transplant recipient that resolved completely with withdrawal of the drug and treatment with corticosteroids.
Output: sirolimus
Reversible sirolimus-associated pneumonitis after heart transplantation.
Output: sirolimus
Two cases of sirolimus-associated pneumonitis have been reported after cardiac transplantation.
Output: sirolimus
An objective causality assessment by use of the Naranjo probability scale revealed that NCSE due to ifosfamide was probable.
Output: ifosfamide
CASE SUMMARIES: Two patients who received ifosfamide-containing chemotherapy developed NCSE.
Output: ifosfamide
CONCLUSIONS: Among the many presentations of ifosfamide neurotoxicity, clinicians should consider NCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
Output: ifosfamide
NCSE, an epileptic disorder in which typical convulsive activity is absent, has previously been reported in only 4 patients receiving ifosfamide.
Output: ifosfamide
Nonconvulsive status epilepticus due to ifosfamide.
Output: ifosfamide
Cutaneous mycobacterial infection post intravesical BCG installation.
Output: BCG
Disseminated tuberculous lesions post intravesical BCG therapy are rare but need to be identified and treated quickly.
Output: BCG
Some patients develop hypersensitivity rash in response to HCQ.
Output: HCQ
Administration of sumatriptan in subarachnoid haemorrhage (SAH) patients, misdiagnosed as migraine patients, may induce symptomatic cerebral vasospasm with potentially dangerous consequences.
Output: sumatriptan
This is the first case of TMP-SMX-induced hypersensitivity syndrome associated with the reactivation of a latent viral infection.
Output: TMP-SMX
Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6.
Output: Trimethoprim-sulfamethoxazole
Hence, hyperthyroidism induced by IFN-alpha could correspond to the first phase of silent thyroiditis, to Graves' disease or to the succession of both.
Output: IFN-alpha
Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.
Output: Interferon-alpha
Dipyrone-induced granulocytopenia: a case for awareness.
Output: Dipyrone
We describe a patient who developed granulocytopenia and fever after taking dipyrone and discuss the available literature.
Output: dipyrone
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
Output: sulfadiazine
This case underscores problems in clinical management with sulfadiazine hypersensitivity, potential immunosuppression from corticosteroids and selection of medications for recurrences of toxoplasmic chorioretinitis.
Output: sulfadiazine
Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature.
Output: paclitaxel
Pulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids.
Output: paclitaxel
Infections are a major adverse effect during the treatment with anti-TNF-alpha.
Output: anti-TNF-alpha
In this case report, we have described a patient with Crohn's disease who developed subfulminant hepatitis B after the fourth infusion of infliximab due to an unrecognized HBs-antigen carrier state.
Output: infliximab
Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?
Output: infliximab
Acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia: a case report.
Output: phenol
We report a 78-year-old man who had acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia.
Output: phenol
Grade 3 hepatotoxicity (AST and ALT > 5 to 20 upper limit normal) or higher has been observed in as many as 1.4% of MS patients on IFN beta.
Output: IFN beta
Allergy to cloxacillin with normal tolerance to amoxicillin and cefuroxime.
Output: cloxacillin
Cardiac toxicity related to BCNU has not been described well.
Output: BCNU
Myocardial ischemia associated with high-dose carmustine infusion.
Output: carmustine
Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of myocardial ischemia during and immediately after BCNU infusion.
Output: BCNU
Adverse reaction in a patient with aspirin-induced asthma treated with zafirlukast.
Output: aspirin
We present a case of hypereosinophilia related to zafirlukast therapy.
Output: zafirlukast
A few recent individual case reports have suggested that a myasthenic syndrome may be associated with statin treatment, but this association is not well described.
Output: statin
Statin-associated myasthenia gravis: report of 4 cases and review of the literature.
Output: Statin
We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a statin drug.
Output: statin
Reactivation of cytomegalovirus probably followed the treatment of Wegener's granulomatosis with corticosteroids and azathioprine.
Output: azathioprine
After excluding other causes of long QT syndrome, the HCQ was suspected as the cause of her ventricular tachycardia.
Output: HCQ
CONCLUSION: The chronic use of HCQ for rheumatic diseases, or as an anti-malarial drug, should be balanced against the risk of developing potentially lethal cardiac arrhythmias.
Output: HCQ
We report a case of chronic use of HCQ associated with torsade de pointes.
Output: HCQ
CONCLUSIONS: The increasing prevalence of Type 2 diabetes and its treatment with metformin might result in more cases of lactic acidosis.
Output: metformin
Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score.
Output: metformin
An unusual presentation of spontaneous sub-conjunctival haematoma in a patient receiving warfarin.
Output: warfarin
The sub-conjunctival haematoma in a patient receiving warfarin can pose a significant management challenge.
Output: warfarin
Angioedema, a rare side effect of carbamazepine, involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins.
Output: carbamazepine
Cutaneous eruptions occur in 3% of individuals administered carbamazepine.
Output: carbamazepine
We report a case of severe AVP three weeks following the administration of infliximab for the treatment of Crohn's disease (CD).
Output: infliximab
First case of ivermectin-induced severe hepatitis.
Output: ivermectin
To our knowledge, this is the first case of ivermectin-induced severe liver disease published in the literature.
Output: ivermectin
We report the case of a 20-year-old woman originally from Cameroon who was infected by the L. loa parasite and developed severe hepatitis, identified 1 month after a single dose of ivermectin.
Output: ivermectin
CONCLUSIONS: This is the second case report that describes gemcitabine-induced radiation recall in rectus abdominus muscles after gemcitabine-based radiation therapy.
Output: gemcitabine
Gemcitabine-induced rectus abdominus radiation recall.
Output: Gemcitabine
Sporadic rippling muscle disease unmasked by simvastatin.
Output: simvastatin
Acute coronary syndrome induced by capecitabine therapy.
Output: capecitabine
This case highlights the possible development of acute coronary syndrome as a side effect of Capecitabine therapy.
Output: Capecitabine
The hepatic enzyme disturbances normalized after discontinuation of pegvisomant.
Output: pegvisomant
PURPOSE: Topiramate-induced angle-closure glaucoma (TiACG) is believed to be related to its sulfonamide moiety.
Output: Topiramate
Spontaneous splenic infarction associated with sumatriptan use.
Output: sumatriptan
We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.
Output: sumatriptan
Acute myocardial infarction during high-dose methylprednisolone therapy for Graves' ophthalmopathy.
Output: methylprednisolone
Except hypothyroidism after radioiodine treatment (euthyroid under substitutional therapy), she suffered from no other diseases.
Output: radioiodine
We conclude that myocardial infarction may develop in patients treated with high-dose glucocorticoids for Graves' ophthalmopathy, and increased blood pressure may herald this complication.
Output: glucocorticoids
Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
Output: sulphasalazine
Five days after the fourth dose of vincristine, she presented with bilateral ptosis.
Output: vincristine
Vincristine induced cranial polyneuropathy.
Output: Vincristine
We describe a 5-year-old girl showed recovery of vincristine induced cranial polyneuropathy with pyridoxine and pyridostigmine treatment.
Output: vincristine
Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test.
Output: morphine
We describe a case of a man treated with an EGFR-inhibitor (erlotinib) for a cell lung cancer who developed skin manifestations localized in an uncommon area and with an atypical evolution.
Output: erlotinib
Olanzapine-associated neuroleptic malignant syndrome.
Output: Olanzapine
Allergic contact angioedema to benzoyl peroxide.
Output: benzoyl peroxide
Factors that suggested an association between the severe angioedematous reaction and BP topical application include the strong reaction to BP in the patch-test, the temporal relationship, the complete resolution of symptoms after the drug was withdrawn and the absence of other identified explanations.
Output: BP
Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.
Output: 5-fluorouracil
We present the case of a 58-year-old woman who ingested more than 35 g of caffeine in a suicide attempt.
Output: caffeine
It may cause a severe adverse drug reaction with multiorgan involvement known as dapsone hypersensitivity syndrome.
Output: dapsone
Severe dapsone hypersensitivity syndrome.
Output: dapsone
We report the case of a 21-year-old female patient with dapsone hypersensitivity syndrome.
Output: dapsone
Anaphylaxis to intrathecal diamorphine.
Output: diamorphine
We believe this is the first report of intrathecal diamorphine causing anaphylaxis.
Output: diamorphine
We highlight two instances of systemic allergic reaction, and discuss the potential side effects of local aprotinin injections in the orthopaedic setting as well as the evidence base for its use.
Output: aprotinin
Localized purpura associated with lamotrigine.
Output: lamotrigine
This case study is the second report of localized purpura after prolonged lamotrigine treatment suggesting this may be an atypical lamotrigine-induced drug reaction.
Output: lamotrigine
This report describes a 13-year-old female with a right frontal high-grade glioma and complex partial seizures who developed localized purpura after 23 months of lamotrigine monotherapy.
Output: lamotrigine
Reversible corneal keratinization following trabeculectomy and treatment with 5-fluorouracil.
Output: 5-fluorouracil
Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
Output: rituximab
Moreover, these findings suggest that the incidence of BOOP following rituximab therapy may be higher than has been previously appreciated.
Output: rituximab
We describe a case of an NHL patient who received rituximab and developed symptomatic, biopsy-proven multinodular bronchiolitis obliterans with organizing pneumonia (BOOP).
Output: rituximab
Despite a very low complication rate, several severe arterial thrombotic events have been reported following thrombin injection of pseudoaneurysms.
Output: thrombin
Lower extremity arterial thrombosis following sonographically guided thrombin injection of a femoral pseudoaneurysm.
Output: thrombin
Native arterial thrombosis, though recognized as a severe complication of thrombin injection, has not been well described in the literature.
Output: thrombin
We report a case of successful surgical management of arterial thrombosis after percutaneous thrombin injection of a femoral artery pseudoaneurysm in a 69-year-old woman.
Output: thrombin
A small number of oxaliplatin-related hemolytic and/or thrombocytopenic reactions have been reported.
Output: oxaliplatin
Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
Output: oxaliplatin
Thus any case of severe neutropenia occurring in a patient receiving olanzapine is alarming to clinicians.
Output: olanzapine
Five months after initiating mirtazapine therapy, she developed symptomatic hyponatremia.
Output: mirtazapine
A 43-year-old woman with multiple sclerosis (MS) had nephrotic syndrome 21 months after starting treatment with interferon (IFN)-beta-1b (subcutaneous administration).
Output: interferon (IFN)-beta-1b
Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.
Output: interferon-beta-1b
A 70-year-old man was admitted to our hospital because of dyspnea after taking an antihistaminic agent (homochlorcyclizine hydrochloride) for itching.
Output: homochlorcyclizine hydrochloride
Acute eosinophilic pneumonia caused by calcium stearate, an additive agent for an oral antihistaminic medication.
Output: calcium stearate
Therefore, we concluded that this patient's pulmonary disease was caused by calcium stearate, an additive for an antihistaminic drug.
Output: calcium stearate
Scleritis complicating zoledronic acid infusion.
Output: zoledronic acid
We present a case of severe unilateral posterior scleritis associated with zoledronic acid administration that was recognized and treated in a timely manner.
Output: zoledronic acid
Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
Output: rituximab
Several such HBV reactivations were reported after combined rituximab and multiagent chemotherapy for B-cell lymphomas.
Output: rituximab
This is the first case of HBV reactivation occurring during the year following rituximab monotherapy in the absence of any other immunosuppressive factor.
Output: rituximab
An intertrigo-like eruption from pegylated liposomal doxorubicin.
Output: doxorubicin
This eruption appears to be a distinct cutaneous toxicity of PLD.
Output: PLD
Exposure of the fetus to indomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus.
Output: indomethacin
Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin.
Output: indomethacin
CONCLUSION: These cases suggest that moxifloxacin may interfere with the healing of corneal ulcers.
Output: moxifloxacin
RESULTS: Both cases presented here describe corneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with moxifloxacin.
Output: moxifloxacin
Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.
Output: fluoroquinolone
Acute generalized exanthematous pustulosis induced by nimesulide.
Output: nimesulide
OBJECTIVE: To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a fatal cardiac arrhythmia after an acute overdose of amphotericin B and to review its toxicity.
Output: amphotericin B
Use of the Naranjo probability scale indicated a highly probable relationship between the observed cardiac toxicity and amphotericin B deoxycholate therapy in this patient.
Output: amphotericin B deoxycholate
The authors describe a case of valvular heart disease in a 48-year-old woman receiving benfluorex (150 mg t.i.d. for 8 years) and leading to surgical mitral valve replacement.
Output: benfluorex
Valvular heart disease in a patient taking benfluorex.
Output: benfluorex
Liver transplantation for fulminant hepatitis related to nevirapine therapy.
Output: nevirapine
The use of cyclosporin has been associated with the development of cholelithiasis in transplant recipients.
Output: cyclosporin
Hepatotoxicity induced by cyproterone acetate: a report of three cases.
Output: cyproterone acetate
Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration.
Output: CPA
Leishmania infantum leishmaniasis in corticosteroid--treated patients.
Output: corticosteroid
However, an association of Ritalin with glaucoma has been reported.
Output: Ritalin
PURPOSE: To describe transient structured visual hallucinations in a patient with vascular age-related macular degeneration (AMD), following an intravitreal Avastin-injection.
Output: Avastin
Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related macular degeneration.
Output: bevacizumab
A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis.
Output: metoclopramide
A case of oculogyric crisis induced by metoclopramide is described in this paper.
Output: metoclopramide
However, cyclosporine dependency is associated with the risk of nephrotoxicity.
Output: cyclosporine
The pathogenic mechanisms involved in the development of adriamycin cardiomyopathy are reviewed, and the possible synergistic effect of other antitumor antibiotics is discussed.
Output: adriamycin
We report the case of a man, treated with mesalazine for Crohn's disease who developed drug-induced pericarditis.
Output: mesalazine
Acute drug induced hepatitis due to erlotinib.
Output: erlotinib
CASE REPORT: We report a case of acute severe hepatitis resulting from erlotinib monotherapy in a patient with locally advanced pancreatic cancer.
Output: erlotinib
Hepatotoxicity resolved once erlotinib was discontinued and serum transaminases returned to baseline normal values.
Output: erlotinib
Even though only a few cases of this adverse event have been reported in the literature, severe docetaxel-induced pulmonary toxicity needs to be considered in the differential diagnosis when such patients present with respiratory symptoms.
Output: docetaxel
Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer.
Output: docetaxel
The case is presented of a 72-year-old man with hormone-refractory prostate cancer and weekly administration of 30 mg/m2 docetaxel who developed subacute interstitial pneumonitis-related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high-dose corticosteroid treatment.
Output: docetaxel
Juvenile absence epilepsy exacerbated by valproic acid.
Output: valproic acid
CONCLUSIONS: Infectious endophthalmitis is a potential complication of intravitreal bevacizumab injection.
Output: bevacizumab
PURPOSE: To report two cases of acute endophthalmitis following intravitreal bevacizumab injection.
Output: bevacizumab
Pulmonary hypertension during lithium therapy: clinical case study.
Output: lithium
The authors presented a case of pulmonary hypertension during lithium therapy, while she has been on lithium for 6 years.
Output: lithium
This is the first report of pulmonary hypertension in an adult patient during lithium therapy.
Output: lithium
The patient's arthritis flared after the second infusion of infliximab, which was discontinued.
Output: infliximab
The risk of new-onset diabetic ketoacidosis in patients with diabetic risk factors who are taking perospirone hydrochloride or other atypical antipsychotics should be kept in mind.
Output: perospirone hydrochloride
Fatal venous thrombembolism complicating imatinib therapy in a patient with metastatic gastrointestinal stromal tumor.
Output: imatinib
The possibility of deep vein thrombosis caused by the compression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with imatinib.
Output: imatinib
Of particular interest in this patient is the fluctuation of the QT interval at a stable dose of methadone, suggesting that a single normal electrocardiogram (ECG) does not guarantee that the patient is not at risk of ventricular arrhythmias.
Output: methadone
We present a case report of a patient who developed a prolonged QT while being treated with oral methadone for a chronic pain syndrome.
Output: methadone
The most serious dental side effect of bisphosphonate treatment (particularly when it is administered intravenously) is, paradoxically, osteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone.
Output: bisphosphonate
Under the suspicion of amiodarone-induced acute pancreatitis, amiodarone was substituted by propafenone.
Output: amiodarone
We report a patient who developed acute pancreatitis during amiodarone therapy.
Output: amiodarone
DISCUSSION: To our knowledge this is the first reported case of tuberculous uveitis following treatment with etanercept.
Output: etanercept
Tuberculous uveitis after treatment with etanercept.
Output: etanercept
We report the first case of tuberculous uveitis due to etanercept.
Output: etanercept
Osteomyelitis occurring during infliximab treatment of severe psoriasis.
Output: infliximab
CONCLUSION: Healthcare professionals should be aware of the possible development of serotonin syndrome as a complication of initiation of fentanyl and other phenylpiperidine opioids in patients treated with SSRIs.
Output: fentanyl
Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
Output: methotrexate
Docetaxel induced Meibomian duct inflammation and blockage is the likely cause of this presentation in a patient with no history of eyelid masses in the past.
Output: Docetaxel
We report a 71-year male with castration-resistant metastatic prostate cancer who was treated with weekly docetaxel for 12 weeks and developed significant eye irritation and dryness during treatment.
Output: docetaxel
A case of recall pneumonitis induced by gemcitabine is reported.
Output: gemcitabine
CONCLUSION: Gemcitabine-induced recall pneumonitis is a rarely reported phenomenon and should be taken into account even after extended time interval to the previous radiotherapy.
Output: Gemcitabine
Radiation recall pneumonitis induced by gemcitabine.
Output: gemcitabine
CONCLUSIONS: For all patients with vancomycin-induced neutropenia, possible cross-reactivity of teicoplanin should be monitored.
Output: vancomycin
However, a new episode of neutropenia, with a WBC count of 2.8 x 10(3)/mm3 and ANC of 0.448 x 10(3)/mm3, occurred 11 days after teicoplanin initiation.
Output: teicoplanin
Cutaneous ulceration: an unusual complication of intravenous pentamidine therapy.
Output: pentamidine
Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.
Output: interferon alpha 2-beta
Flecainide overdose can rapidly result in profound cardiovascular collapse, and is associated with a relatively high mortality.
Output: Flecainide
Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy.
Output: flecainide
Ezetimibe-induced acute pancreatitis.
Output: Ezetimibe
Since its FDA approval in 2002, there are no known citations of ezetimibe-induced pancreatitis.
Output: ezetimibe
Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
Output: raloxifene
This is the first histologically confirmed case of NASH that was aggravated by raloxifene.
Output: raloxifene
A case of liver damage following treatment with Danazol for fibrocystic breast disease is reported.
Output: Danazol
Hepatic damage after danazol treatment.
Output: danazol
Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.
Output: lenalidomide
Thus, the patient's clinical course and workup strongly support a diagnosis of lenalidomide-induced hypersensitivity pneumonitis-like syndrome.
Output: lenalidomide
Intravitreal triamcinolone may have had an influence on the exacerbation of retinochoroiditis in the posterior pole of the patient.
Output: triamcinolone
A 40-year-old man with advanced HIV infection and Mycobacterium avium complex infection experienced rapid cognitive decline after commencement of ethambutol, and symptoms fully resolved with cessation.
Output: ethambutol
Ethambutol toxicity manifesting as acute onset psychosis.
Output: Ethambutol
Psoriasis induced by interferon-alpha.
Output: interferon-alpha
Recombinant human interferon-alpha has been used in the treatment of several cancers, but there have been several reports that it may exacerbate psoriasis or trigger off its onset.
Output: Recombinant human interferon-alpha
We report four patients, three of whom first developed psoriasis and one who had an aggravation of the condition during treatment with interferon-alpha.
Output: interferon-alpha
Neurointensive care management of raised intracranial pressure caused by severe valproic acid intoxication.
Output: valproic acid
Bleomycin induced hyperpigmentation with yolk sac tumor.
Output: Bleomycin
The hyperpigmentation was diffuse scattered, flagellate like and linear streaking which was thought to be mainly related to the skin toxicity of bleomycin.
Output: bleomycin
A cause-effect relationship to capecitabine was suggested due to resolution of headache with capecitabine withdrawal and reappearance with capecitabine rechallenge.
Output: capecitabine
BACKGROUND: Headaches have been reported as a potential side effect of capecitabine therapy.
Output: capecitabine
Capecitabine-induced headache responding to diltiazem.
Output: Capecitabine
The patient developed grade 3 capecitabine-induced headache.
Output: capecitabine
We hypothesize that capecitabine-induced headache is vascular in nature.
Output: capecitabine
Paralytic ileus in patients undergoing bortezomib treatment has been reported, although a definite attribution to bortezomib administration has not been established.
Output: bortezomib
We report a myeloma patient who developed severe paralytic ileus during bortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.
Output: bortezomib
A woman developed delusional parasitosis when taking phenelzine.
Output: phenelzine
Delusional parasitosis associated with phenelzine.
Output: phenelzine
The use of rituximab has been uncommonly associated with delayed pulmonary toxicity.
Output: rituximab
Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene.
Output: metoclopramide
We report a case of fulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six-hourly intravenous metoclopramide.
Output: metoclopramide
The clinical symptoms of gastric mucosa foveolar hyperplasia due to long-term PGE1 therapy simulate hypertrophic pyloric stenosis.
Output: PGE1
The results of the ultrasound examination combined with clinical anamnesis allowed diagnosis of gastric mucosa foveolar hyperplasia due to prolonged PGE1 therapy.
Output: PGE1
A case of colchicine-induced rhabdomyolysis is reported.
Output: colchicine
Colchicine-induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
Output: Colchicine
Colchicine-induced rhabdomyolysis.
Output: Colchicine
Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of colchicine resulted in resolution of clinical and biochemical features of rhabdomylysis.
Output: colchicine
5-Fluorouracil cardiotoxicity complicating treatment of stage IIB cervical cancer--case report.
Output: 5-Fluorouracil
CONCLUSION: Acetic acid is corrosive and may cause vagina bleeding.
Output: Acetic acid
Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.
Output: interferon-gamma
We assume that rIFN-gamma induced the de novo development of SLE in our patient.
Output: rIFN-gamma
Bisphosphonate induced osteochemonecrosis of the jaw mimicking a tumour.
Output: Bisphosphonate
Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
Output: Clozapine
Drug-induced eosinophilia is a non-dose-dependent side effect of clozapine.
Output: clozapine
Occasionally, despite good therapeutic response, clozapine must be stopped due to dangerous side effects such as agranulocytosis.
Output: clozapine
Metformin-associated lactic acidosis precipitated by diarrhea.
Output: Metformin
The dermatology literature heretofore has not noted that anemia is a side effect of patients taking MMF to treat pemphigus.
Output: MMF
A search of the United States Food and Drug Administration's Adverse Event Reporting System identified nine cases of oxcarbazepine-associated angioedema in pediatric patients aged 16 years and younger.
Output: oxcarbazepine
Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review.
Output: oxcarbazepine
Oxcarbazepine-associated angioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing (or both) is a rare but potentially life-threatening reaction for which early recognition and management are vital.
Output: Oxcarbazepine
We describe in detail the first U.S. case report, of a 4(1/2)-year-old boy who experienced angioedema during treatment with oxcarbazepine.
Output: oxcarbazepine
Here we describe another case of VOD occurring after LT, but in which the causative role was played by azathioprine.
Output: azathioprine
One case of tacrolimus-induced hepatic VOD developing after lung transplantation (LT) has been recently reported.
Output: tacrolimus
Carbamazepine hypersensitivity syndrome is a rare, life-threatening condition.
Output: Carbamazepine
A patient with chronic myelomonocytic leukemia developed drug-induced pulmonary toxicity after using low dose oral etoposide.
Output: etoposide
Because etoposide-induced pulmonary toxicity is an uncommon but serious adverse event, clinicians must be vigilant about the possibility of it, so that the optimal treatment can start as soon as possible.
Output: etoposide
PET scintigraphy of etoposide-induced pulmonary toxicity.
Output: etoposide
Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
Output: L-tryptophan
The Center for Disease Control has received numerous reports of an eosinophilia-myalgia syndrome related to products containing L-tryptophan.
Output: L-tryptophan
Here, we report a case of RFP-induced hypothyroidism without underlying thyroid disease.
Output: RFP
Rifampin-induced hypothyroidism without underlying thyroid disease.
Output: Rifampin
A patient is described who developed a rapid onset of pulmonary fibrosis following treatment with a new non-steroidal anti-inflammatory drug, nabumetone.
Output: nabumetone
Pulmonary fibrosis associated with nabumetone.
Output: nabumetone
Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.
Output: interferon alpha
It is tempting to speculate that interferon alpha may be involved in the pathogenesis of lichen nitidus.
Output: interferon alpha
Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation.
Output: clopidogrel
Treatment of APL in pregnancy is controversial as the use of ATRA has been questioned due to the teratogenic effect of retinoids.
Output: ATRA
Pulmonary toxicity associated with erlotinib.
Output: erlotinib
This case and other published evidence should alert physicians to the possibility of fatal erlotinib-induced ILD.
Output: erlotinib
We report a case of fatal pulmonary toxicity in a patient with advanced non-small cell lung cancer who received erlotinib.
Output: erlotinib
It has been reported that fluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause torsade de pointes.
Output: fluoroquinolone
Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.
Output: moxifloxacin
Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.
Output: methotrexate
CASE REPORT: A six-year-old boy with transfusion-dependent beta-thalassaemia developed a unilateral hearing loss shortly after commencing desferrioxamine therapy.
Output: desferrioxamine
Leflunomide-associated infections in rheumatoid arthritis.
Output: Leflunomide
The NZ Pharmacovigilance Centre has received 7 additional reports of severe infections in patients with RA taking leflunomide.
Output: leflunomide
This case illustrates that the hemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking sulfasalazine.
Output: sulfasalazine
Uncontrolled headache induced by oxcarbazepine.
Output: oxcarbazepine
CONCLUSION: A patient with CHF and ESRD developed myoclonic muscle spasms after receiving dobutamine by continuous i.v. infusion.
Output: dobutamine
Myoclonus associated with continuous dobutamine infusion in a patient with end-stage renal disease.
Output: dobutamine
PURPOSE: The occurrence of myoclonus associated with continuous i.v. infusion of dobutamine in a patient with end-stage renal disease (ESRD) is described.
Output: dobutamine
Psychosis in a 12-year-old HIV-positive girl with an increased serum concentration of efavirenz.
Output: efavirenz
We report (to our knowledge, for the first time in a child) the emergence of psychosis in a 12-year old white girl with an increased efavirenz concentration and heterozygous gene polymorphism of the CYP2B6-G516T.
Output: efavirenz
Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab.
Output: infliximab
Sustained monomorphic ventricular tachycardia after adenosine infusion.
Output: adenosine
We present a case of a sustained monomorphic ventricular tachycardia following adenosine infusion.
Output: adenosine
Surprisingly, we found that three patients appeared to develop tardive OGC while taking clozapine.
Output: clozapine
Tardive oculogyric crisis during treatment with clozapine: report of three cases.
Output: clozapine
Metronidazole neuropathy.
Output: Metronidazole
Two patients are described who developed sensory neuropathy after the ingestion of 30.6 and 114 g metronidazole respectively.
Output: metronidazole
We report a case of a patient with rheumatoid arthritis treated with low-dose methotrexate (15 mg/week) who developed infection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip.
Output: methotrexate
DIAGNOSIS: Sustained ventricular tachycardia possibly owing to thalidomide treatment.
Output: thalidomide
Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
Output: thalidomide
A patient developed typical ECM after subcutaneous selfinjection of glatiramer acetate for multiple sclerosis.
Output: glatiramer acetate
Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate.
Output: glatiramer acetate
This case is remarkable since 1) ECM developed after subcutaneous and not after intramuscular injection, 2) the injection was given by the patient himself, and 3) glatiramer acetate can induce skin necrosis as a side effect.
Output: glatiramer acetate
Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with amiodarone-induced hypothyroidism and that involution changes represent the hypofunctional status of this drug-induced disorder.
Output: amiodarone
Amiodarone is well recognized as an anti-arrhythmic drug containing a high dose of iodine with considerable potential to cause thyroid dysfunction.
Output: Amiodarone
Histopathology of the thyroid in amiodarone-induced hypothyroidism.
Output: amiodarone
This is the first report on the histopathological findings of thyroid tissue from a patient with amiodarone-induced hypothyroidism.
Output: amiodarone
Amphotericin B-induced cutaneous leucocytoclastic vasculitis: case report.
Output: Amphotericin B
Palpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of amphotericin B treatment.
Output: amphotericin B
We present a case of cutaneous leucocytoclastic vasculitis in which amphotericin B might presumably be the aetiological factor.
Output: amphotericin B
Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil.
Output: 5-fluorouracil
We report such a series of patients who had transient asymptomatic bradycardia after being treated with continuous infusion 5-FU.
Output: 5-FU
According to the Naranjo probability scale, the papular eruption was probably caused by methotrexate.
Output: methotrexate
CONCLUSIONS: The pathogenesis of methotrexate-induced papular eruption in collagen vascular diseases may suggest cutaneous small-vessel vasculitis.
Output: methotrexate
DISCUSSION: Methotrexate-induced papular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
Output: Methotrexate
Methotrexate-induced papular eruption following treatment of psoriasis has not been previously reported.
Output: Methotrexate
Methotrexate-induced papular eruption following treatment of psoriasis.
Output: Methotrexate
OBJECTIVE: To report a case of a diffuse papular eruption following treatment of psoriasis with methotrexate injections.
Output: methotrexate
Ten hours after the second methotrexate injection, the patient experienced a diffuse pruritic papular eruption located mainly on the limbs.
Output: methotrexate
Metabolic acidosis induced by acetazolamide.
Output: acetazolamide
Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
Output: acetylsalicylic acid
The authors describe pericardial hemorrhage, which is related to the use of low-dose acetylsalicylic acid in a patient with essential thrombocythemia.
Output: acetylsalicylic acid
Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.
Output: methotrexate
This case demonstrates the value of DWI in evaluation and diagnosis of sub-acute toxic leukoencephalopathy in patients being treated with methotrexate.
Output: methotrexate
We describe longitudinal diffusion-weighted MRI findings of sub-acute leukoencephalopathy following methotrexate therapy in a 24-year-old man diagnosed with pre-B-cell acute lymphoblastic leukemia (ALL), presenting with right-sided paralysis and aphasia after second consolidation with intrathecal triple-drug therapy given intrathecally.
Output: methotrexate
New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
Output: etanercept
Typical symptoms of active CD occurred 11, 12, and 26 months after start of etanercept therapy, respectively.
Output: etanercept
We describe 3 AS patients treated with etanercept for active AS who developed new onset of CD while AS related symptoms responded well to etanercept.
Output: etanercept
Severe hepatocellular dysfunction following cyproterone acetate therapy.
Output: cyproterone acetate
She was treated with acyclovir and subsequently developed VZV antigen-positive zoster.
Output: acyclovir
According to the Naranjo adverse drug reaction probability scale, the likelihood that temozolomide was responsible for the adverse drug reaction of fever was probable (score of 6).
Output: temozolomide
Clinicians should be aware that an erythematous and exfoliative rash may be induced by temozolomide, and be familiar with the pharmacologic and supportive measures necessary for its treatment.
Output: temozolomide
Due to the severity of the rash, temozolomide was permanently discontinued.
Output: temozolomide
Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma.
Output: Temozolomide
Temozolomide was restarted 2 months later; the patient again developed a fever.
Output: Temozolomide
Exfoliative dermatitis secondary to tobramycin sulfate.
Output: tobramycin sulfate
We report a case of exfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of tobramycin.
Output: tobramycin
Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Output: Rituximab-CHOP
Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
Output: Phenytoin
A diagnosis of trastuzumab-induced pneumonitis was made.
Output: trastuzumab
Life-threatening interstitial lung disease associated with trastuzumab: case report.
Output: trastuzumab
Allergic contact dermatitis from 4-chloro-7-nitrobenzofurazan.
Output: 4-chloro-7-nitrobenzofurazan
We report the case of a woman who developed photo-onycholysis on multiple nails after uptake of olanzapine.
Output: olanzapine
Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis.
Output: leflunomide
Hyponatraemia developed after rechallenge with controlled release carbamazepine.
Output: carbamazepine
Hyponatraemia during low-dose carbamazepine therapy.
Output: carbamazepine
We report the syndrome of inappropriate antidiuresis as a much earlier side-effect of carbamazepine administration in a 29-year Nigerian female patient with generalized tonic-elonic seizures.
Output: carbamazepine
In the present paper, we describe two patients with active UC who developed a severe systemic CMV infection during a treatment with an oral microemulsion form of cyclosporine.
Output: cyclosporine
A short review on imatinib-related hepatotoxicity is also presented.
Output: imatinib
Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Output: Imatinib mesylate
Up to four percent of patients treated with imatinib may develop hepatotoxicity, which usually resolves with discontinuation of the drug.
Output: imatinib
CONCLUSIONS: Clinicians treating elderly patients with olanzapine should be aware of the potential for rapidly developing hyperglycemia and monitor such patients accordingly.
Output: olanzapine
OBJECTIVE: To report a case of rapidly occurring hyperglycemia that occurred in a geriatric patient 3 days after treatment with olanzapine.
Output: olanzapine
Rapidly developing hyperglycemia during treatment with olanzapine.
Output: olanzapine
Subsequently, he developed hyperglycemia (fasting blood glucose 138 mg/dL) that resolved when olanzapine was stopped and recurred (fasting blood glucose 150 mg/dL) after 2 days of rechallenge with olanzapine 2.5 mg twice daily.
Output: olanzapine
There have been numerous case reports of hyperglycemia with olanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.
Output: olanzapine
Bilateral anterior uveitis associated with clomiphene citrate.
Output: clomiphene citrate
PURPOSE: To report a case of bilateral anterior uveitis associated with ovulation induction therapy using clomiphene citrate.
Output: clomiphene citrate
Development of tics in a thirteen-year-old male following atomoxetine use.
Output: atomoxetine
There are, however, case studies describing patients experiencing recurrences of tics following treatment with atomoxetine.
Output: atomoxetine
BACKGROUND: To describe the occurrence of ocular hypertension in four patients following injection of ranibizumab intravitreally.
Output: ranibizumab
CONCLUSION: Severe and sustained ocular hypertension may occur after intravitreal ranibizumab.
Output: ranibizumab
Ocular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.
Output: ranibizumab
Persisent ocular hypertension following intravitreal ranibizumab.
Output: ranibizumab
Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy.
Output: efalizumab
We report a 45-year-old psoriasis patient who developed eruptive mollusca contagiosa during an antipsoriatic treatment with efalizumab.
Output: efalizumab
Incomplete posterior hyaloid detachment after intravitreal pegaptanib injection in diabetic macular edema.
Output: pegaptanib
The authors report one case of incomplete posterior hyaloid detachment (PHD) following intravitreal pegaptanib to treat DME.
Output: pegaptanib
Enalaprilat induced acute parotitis.
Output: Enalaprilat
We present here a female patient who developed acute bilateral parotitis within minutes of i.v. enalaprilat injection and recovered within 24 hours of stopping the drug and with symptomatic treatment.
Output: enalaprilat
Severe symptomatic hyponatremia during sibutramine therapy: a case report.
Output: sibutramine
We describe a case of life-threatening hyponatremia associated with sibutramine use in an obese woman.
Output: sibutramine
Our findings reveal that even in patients without a history of seizures, pregabalin can cause a cortical negative myoclonus.
Output: pregabalin
Pregabalin-induced cortical negative myoclonus in a patient with neuropathic pain.
Output: Pregabalin
We describe a patient who, after receiving his first dose of pregabalin to relieve neuropathic pain, presented with a negative myoclonus.
Output: pregabalin
Muzolimine-induced severe neuromyeloencephalopathy: report of seven cases.
Output: Muzolimine
We report on 7 patients (2 women, 5 men) with chronic renal failure, who developed under a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day) fatal neuromyeloencephalopathy.
Output: muzolimine